Trial Outcomes & Findings for Clinical Trial Evaluating the Efficiency of Holmium Laser Settings on Urinary Stones (NCT NCT03526458)

NCT ID: NCT03526458

Last Updated: 2021-09-20

Results Overview

The time to fragment a stone into small pieces (≤2 mm, which is our current institutional practice)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

40 participants

Primary outcome timeframe

up to 6 hours

Results posted on

2021-09-20

Participant Flow

Participant milestones

Participant milestones
Measure
Holmium:YAG Laser: 0.2J&15Hz
Patients are assigned to treat stones with 0.2J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Holmium:YAG Laser: 0.8J&15Hz
Patients are assigned to treat stones with 0.8J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Overall Study
STARTED
20
20
Overall Study
COMPLETED
12
15
Overall Study
NOT COMPLETED
8
5

Reasons for withdrawal

Reasons for withdrawal
Measure
Holmium:YAG Laser: 0.2J&15Hz
Patients are assigned to treat stones with 0.2J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Holmium:YAG Laser: 0.8J&15Hz
Patients are assigned to treat stones with 0.8J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Overall Study
Surgeries rescheduled or cancelled due to COVID
2
2
Overall Study
Stone passed, surgery cancelled
2
1
Overall Study
Withdrawal by Subject
1
0
Overall Study
Physician Decision
2
1
Overall Study
Lack of equipment
1
1

Baseline Characteristics

Clinical Trial Evaluating the Efficiency of Holmium Laser Settings on Urinary Stones

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Holmium:YAG Laser: 0.2J&15Hz
n=12 Participants
Patients are assigned to treat stones with 0.2J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Holmium:YAG Laser: 0.8J&15Hz
n=15 Participants
Patients are assigned to treat stones with 0.8J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Total
n=27 Participants
Total of all reporting groups
Age, Continuous
51 years
STANDARD_DEVIATION 15.4 • n=5 Participants
55.6 years
STANDARD_DEVIATION 13.1 • n=7 Participants
53.6 years
STANDARD_DEVIATION 14.1 • n=5 Participants
Sex: Female, Male
Female
5 Participants
n=5 Participants
8 Participants
n=7 Participants
13 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
7 Participants
n=7 Participants
14 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants
n=5 Participants
15 Participants
n=7 Participants
27 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
12 Participants
n=5 Participants
15 Participants
n=7 Participants
27 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
12 participants
n=5 Participants
15 participants
n=7 Participants
27 participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 6 hours

The time to fragment a stone into small pieces (≤2 mm, which is our current institutional practice)

Outcome measures

Outcome measures
Measure
Holmium:YAG Laser: 0.2J&15Hz
n=12 Participants
Patients are assigned to treat stones with 0.2J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Holmium:YAG Laser: 0.8J&15Hz
n=15 Participants
Patients are assigned to treat stones with 0.8J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Fragmentation Time
24.5 Minutes
Standard Deviation 19.2
7.9 Minutes
Standard Deviation 3.2

SECONDARY outcome

Timeframe: up to 6 hours

Outcome measures

Outcome measures
Measure
Holmium:YAG Laser: 0.2J&15Hz
n=12 Participants
Patients are assigned to treat stones with 0.2J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Holmium:YAG Laser: 0.8J&15Hz
n=15 Participants
Patients are assigned to treat stones with 0.8J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Total Operative Time
75.7 Minutes
Standard Deviation 20.6
64.3 Minutes
Standard Deviation 17.2

SECONDARY outcome

Timeframe: Retrospective review of health chart at Baseline

Pre-operative stone size (on pre-operative CT) will be reported in millimeters.

Outcome measures

Outcome measures
Measure
Holmium:YAG Laser: 0.2J&15Hz
n=12 Participants
Patients are assigned to treat stones with 0.2J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Holmium:YAG Laser: 0.8J&15Hz
n=15 Participants
Patients are assigned to treat stones with 0.8J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Pre-Operative Stone Size
11.2 mm
Standard Deviation 5.2
9.2 mm
Standard Deviation 8.2

SECONDARY outcome

Timeframe: up to 6 hours

Urinary stone location will be classified as renal or ureter.

Outcome measures

Outcome measures
Measure
Holmium:YAG Laser: 0.2J&15Hz
n=12 Participants
Patients are assigned to treat stones with 0.2J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Holmium:YAG Laser: 0.8J&15Hz
n=15 Participants
Patients are assigned to treat stones with 0.8J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Number of Participants With Either Ureteral or Renal Location of Urinary Stone
Ureteral
8 Participants
7 Participants
Number of Participants With Either Ureteral or Renal Location of Urinary Stone
Renal
4 Participants
8 Participants

SECONDARY outcome

Timeframe: up to 6 hours

Outcome measures

Outcome measures
Measure
Holmium:YAG Laser: 0.2J&15Hz
n=12 Participants
Patients are assigned to treat stones with 0.2J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Holmium:YAG Laser: 0.8J&15Hz
n=15 Participants
Patients are assigned to treat stones with 0.8J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Number of Participants Treated for Either Single or Multiple Urinary Stones
Single
8 Participants
14 Participants
Number of Participants Treated for Either Single or Multiple Urinary Stones
Multiple
4 Participants
1 Participants

SECONDARY outcome

Timeframe: up to 6 hours

Outcome measures

Outcome measures
Measure
Holmium:YAG Laser: 0.2J&15Hz
n=12 Participants
Patients are assigned to treat stones with 0.2J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Holmium:YAG Laser: 0.8J&15Hz
n=15 Participants
Patients are assigned to treat stones with 0.8J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Density of Urinary Stones
935.2 Hounsfield units
Standard Deviation 367.9
924.7 Hounsfield units
Standard Deviation 374.5

SECONDARY outcome

Timeframe: up to 6 hours

Size of fragments created will be assessed using the laser fiber size as a comparison.

Outcome measures

Outcome measures
Measure
Holmium:YAG Laser: 0.2J&15Hz
n=12 Participants
Patients are assigned to treat stones with 0.2J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Holmium:YAG Laser: 0.8J&15Hz
n=15 Participants
Patients are assigned to treat stones with 0.8J\&15Hz of the holmium laser. Holmium:YAG laser: Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm
1mm
1 Participants
5 Participants
Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm
2mm
10 Participants
10 Participants
Number of Participants With Urinary Stone Fragment Size of 1, 2 or 3 mm
3mm
1 Participants
0 Participants

Adverse Events

Holmium:YAG Laser: 0.2J&15Hz

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Holmium:YAG Laser: 0.8J&15Hz

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Shuang Li

University of Wisconsin, School of Medicine and Public Health, Department of Urology

Phone: 6082638336

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place